Differentiated approach and indications for optimization of agomelatine therapy for endogenous depression
Objective: to develop and justify differentiated indications for the use of agomelatine (valdoxan) to treat the typological variants of endogenous depressions with varying severity on the basis of an analysis of its therapeutic efficacy.Patients and methods. An open prospective study was conducted u...
Main Authors: | L. I. Abramova, G. P. Panteleeva, I. Yu. Nikiforova, T. E. Novozhenova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2019-06-01
|
Series: | Неврология, нейропсихиатрия, психосоматика |
Subjects: | |
Online Access: | https://nnp.ima-press.net/nnp/article/view/1103 |
Similar Items
-
Agomelatine – pharmacological properties and use in psychiatric practice
by: Marcin Siwek, et al.
Published: (2019-06-01) -
Agomelatine in the treatment of anhedonia, somatic symptoms, and sexual dysfunction in major depressive disorder
by: Juan Huang, et al.
Published: (2023-04-01) -
Evidence-Based Pharmacotherapy of Anxiety Symptoms in Patients with Major Depressive Disorder: Focus on Agomelatine
by: Dan J. Stein
Published: (2023-04-01) -
Comparing the effect of agomelatine and sertraline in treating patients with major depression disorder
by: Afshin Ahmadvand, et al.
Published: (2023-09-01) -
Agomelatine in the treatment of mild-to-moderate depression in patients with cardiovascular disease: results of the national multicenter observational study PULSE
by: Medvedev VE
Published: (2017-04-01)